中国实用医药
中國實用醫藥
중국실용의약
CHINA PRACTICAL MEDICAL
2015年
8期
38-39
,共2页
奥扎格雷钠%疏血通注射液%急性脑梗死
奧扎格雷鈉%疏血通註射液%急性腦梗死
오찰격뢰납%소혈통주사액%급성뇌경사
Ozagrel sodium%Shuxuetong injection%Acute cerebral infarction
目的:观察奥扎格雷钠联合疏血通注射液治疗急性脑梗死患者的疗效。方法120例急性脑梗死患者随机分为奥扎格雷钠与疏血通注射液联合治疗组(n=60)和疏血通注射液单药对照组(n=60),疗程为14 d,研究观察两组间的疗效差别及治疗前后神经功能缺损程度恢复情况。结果两组患者总有效率比较(93.3%VS78.3%)差异有统计学意义(P<0.05);两组患者治疗后14 d神经功能缺损评分比较[(5.41±2.28)分VS(8.54±2.49)分]差异有统计学意义(P<0.05)。结论奥扎格雷钠联合疏血通注射液治疗急性脑梗死较单用疏血通注射液临床效果明显,安全性高。
目的:觀察奧扎格雷鈉聯閤疏血通註射液治療急性腦梗死患者的療效。方法120例急性腦梗死患者隨機分為奧扎格雷鈉與疏血通註射液聯閤治療組(n=60)和疏血通註射液單藥對照組(n=60),療程為14 d,研究觀察兩組間的療效差彆及治療前後神經功能缺損程度恢複情況。結果兩組患者總有效率比較(93.3%VS78.3%)差異有統計學意義(P<0.05);兩組患者治療後14 d神經功能缺損評分比較[(5.41±2.28)分VS(8.54±2.49)分]差異有統計學意義(P<0.05)。結論奧扎格雷鈉聯閤疏血通註射液治療急性腦梗死較單用疏血通註射液臨床效果明顯,安全性高。
목적:관찰오찰격뢰납연합소혈통주사액치료급성뇌경사환자적료효。방법120례급성뇌경사환자수궤분위오찰격뢰납여소혈통주사액연합치료조(n=60)화소혈통주사액단약대조조(n=60),료정위14 d,연구관찰량조간적료효차별급치료전후신경공능결손정도회복정황。결과량조환자총유효솔비교(93.3%VS78.3%)차이유통계학의의(P<0.05);량조환자치료후14 d신경공능결손평분비교[(5.41±2.28)분VS(8.54±2.49)분]차이유통계학의의(P<0.05)。결론오찰격뢰납연합소혈통주사액치료급성뇌경사교단용소혈통주사액림상효과명현,안전성고。
Objective To observe the curative effect of ozagrel sodium combined with Shuxuetong injection in the treatment of acute cerebral infarction. Methods A total of 120 patients with acute cerebral infraction were randomly divided into ozagrel sodium combined with Shuxuetong injection group (n=60) and single Shuxuetong injection group (n=60). The treatment lasted for 14 d, and observations were made on curative effects and nervous functional defects recovery. Results The difference of total effective rates between the two groups (93.3%VS 78.3%) had statistical significance (P<0.05). The difference of 14 d nervous functional defects scores between the two groups after treatment[(5.41±2.28) points VS (8.54±2.49) points]had statistical significance (P<0.05). Conclusion Combination of ozagrel sodium and Shuxuetong injection has better clinical effect and safety than single Shuxuetong injection treatment for acute cerebral infraction.